BRANCA BUNUS LIMITED

Branca Bunus Ltd is a specialised gene‑therapy company that develops safe gene medicines and high‑performance transfection reagents for the life‑science sector. Drawing on its proprietary HPAEs platform technology, the firm delivers robust solutions that streamline viral‑vector transient production for cell and gene‑therapy programmes, as well as protein‑expression workflows.

The company’s core offering centres on transfection reagents that combine superior efficiency, high cell‑viability and easy scalability—from modest academic labs to large‑scale CDMO operations. Branca Bunus also provides custom‑designed formulations for the targeted delivery of pDNA, siRNA, mRNA and CRISPR complexes, both in‑vitro and in‑vivo, backed by dedicated technical support and training. Its products are already trusted by leading biotech and pharmaceutical organisations, helping customers accelerate research while reducing costs.

Based in the Cherrywood Business Park in Dublin, Branca Bunus serves researchers, contract development and manufacturing organisations, and biotech and pharmaceutical companies seeking reliable, cost‑effective transfection tools that drive breakthrough discoveries.